Communiqués Medicure Inc.

Actions

MPH

CA58469E4085

Recherche biotechnologique et médicale

Temps Différé Toronto S.E. 17:12:42 10/09/2026			Varia. 5j.	Varia. 1 janv.
2,590 ^CAD	0,00%		+5,71%	+127,19%

09/09	Medicure présente le protocole de l'étude de phase 3 MEND-PNPO et les données de référence au 16ème Congrès européen sur l'épilepsie	CI
17/08	Transcript : Medicure Inc., Q2 2026 Earnings Call, Aug 17, 2026

Communiqués

09/09	Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress	AQ
14/08	Medicure: Q2 Earnings Snapshot	AQ
14/08	Medicure : Q2 - June 30, 2026 (medicure q2 2026 financial statements)	PU
14/08	Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call	AQ
06/07	MEDICURE ANNOUNCES CFO CHANGE	AQ
03/07	Medicure Announces CFO Change	AQ
21/05	Medicure : Press Release (medicure reports financial results for quarter ended march 31 2026 and schedules may 25 2026 conference call)	PU
21/05	Medicure : Q1 - March 31, 2026 (medicure q1 2026 financial statements)	PU
21/05	Medicure: Q1 Earnings Snapshot	AQ
21/05	Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call	AQ
21/05	Medicure Announces AGM Results and Appointment of New Director	AQ
04/05	Medicure : Investor Presentation (medicure investor presentation 2026 05 04)	PU
24/04	Medicure : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F)	PU
24/04	Medicure: Q4 Earnings Snapshot	AQ
24/04	Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call	AQ
21/04	Medicure : Notice & Management Information Circular (info circular final april 2026)	PU
21/04	Medicure : Form of Proxy (form of proxy 2026)	PU
21/04	Medicure : Notice of Meeting (notice of meeting april 2026)	PU
18/04	Medicure Announces Resignation of President and Chief Operating Officer	AQ
20/11	MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2025	AQ
19/11	Medicure : Q3 - September 30, 2025 (medicure nov 2025 q3 financial results)	PU
19/11	Medicure: Q3 Earnings Snapshot	AQ
23/09/25	MEDICURE : ANNOUNCES UPDATE ON ENROLLMENT IN ITS MEND-PNPO PHASE 3 CLINICAL TRIAL AND PRESENTATION OF THE TRIAL DESIGN AND BASELINE DATA AT THE 2025 CHILD NEUROLOGY SOCIETY CONFERENCE	PU
21/08/25	MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2025	AQ
21/08/25	Medicure : Q2 - June 30, 2025 (medicure inc q2 2025 results)	PU